FIELD: nuclear medicine.
SUBSTANCE: invention relates to the field of nuclear medicine; it can be used to obtain an isotope of radium-223 of medical purity. The method consists in preliminary deep purification of thorium-227 from the parent actinium-227 on a strong anionite (AB-17) by elution of the latter with 8 mol/l of nitric acid, washing thorium-227 from the anionite in the minimum volume of eluate, which is achieved by using 2 mol/l of hydrochloric acid as eluate. Next, thorium is transferred to a solution of 8 mol/l of nitric acid and radium-223 accumulated after a certain exposure on anionite is isolated by elution with 8 mol/l of nitric acid.
EFFECT: provided is possibility to reliably prevent contamination of radium-223 preparation with actinium-227 and minimize its contamination with products of destruction of organic carriers.
1 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING ISOTOPE | 2016 |
|
RU2768732C2 |
COMPOSITION FOR PRODUCING RADIOPHARMACEUTICALS BASED ON ALPHA-EMITTING NUCLIDES: RADIUM-223, RADIUM-224, ACTINIUM-225 AND DAUGHTER NUCLIDES THEREOF | 2020 |
|
RU2760323C1 |
METHOD OF PRODUCING ACTINIUM-225 AND RADIUM ISOTOPES AND TARGET FOR REALISING SAID METHOD (VERSIONS) | 2008 |
|
RU2373589C1 |
METHOD OF PRODUCING ACTINIUM-227, THORIUM-228 AND THORIUM-229 FROM IRRADIATED RADIUM-226 | 2019 |
|
RU2716272C1 |
METHOD TO PRODUCE RADIONUCLIDE BISMUTH-212 | 2010 |
|
RU2439727C1 |
METHOD OF PREPARING NON-SUPPORTED RADIONUCLIDE ACTINIUM-225 | 2001 |
|
RU2200581C1 |
METHOD FOR GENERATOR PRODUCTION OF BISMUTH-213 THROUGH SEPARATION AND DECAY OF FRANCIUM-221 | 2021 |
|
RU2778249C1 |
METHOD OF OBTAINING PB/BI FOR NUCLEAR MEDICINE | 2020 |
|
RU2742138C1 |
METHOD FOR OBTAINING ACTINIUM-225 | 2017 |
|
RU2666343C1 |
METHOD OF PRODUCING ACTINIUM-225 | 2019 |
|
RU2725414C1 |
Authors
Dates
2021-08-11—Published
2020-05-13—Filed